Cutting-Edge Research. Translational Science.

CorriXR Therapeutics Appoints Jan Case as Chief Operating Officer

Publication: Business Wire

4 companies to watch in the accelerating gene editing race

Publication: PharmaVoice

CorriXR Therapeutics Names Eric Kmiec Chief Executive Officer

Publication: Business Wire

CorriXR Therapeutics Appoints Jill Castilla to Its Board of Directors

Publication: Business Wire

Precision Medicine in Delaware: Working to treat every body according to its genetic makeup

Publication: Delaware Business Times

RealLIST Connectors 2024: Meet 20 of the most impactful leaders in Delaware’s innovation scene

Publication: Technical.ly

CorriXR: How This Company Is Using CRISPR/Cas Gene Editing To Develop New Medicines

Publication: Pulse 2.0

RealLIST Startups 2024: Delaware’s most promising early-stage companies

Publication: Technical.ly

CorriXR sees investment from Oklahoma investment firm

Publication: Delaware Business Times

Therapeutic Gene Editing: A Lot Done, a Lot More to Do. Interview with Eric Kmiec, Ph.D.

Publication: CRISPR Medicine News

Cortado Ventures Invests in CorriXR

Source: Cortado Ventures

ChristianaCare spinout CorriXR is off to the races

Publication: Technical.ly

CorriXR Therapeutics names Moorad as new CEO

Publication: Delaware Business Times

CorriXR Therapeutics Announces Deborah Moorad as Its New Chief Executive Officer

Publication: Business Wire

Eric Kmiec, Ph.D., Named Editor-in-Chief of Gene and Genome Editing

Publication: ChristianaCare News

Education & Healthcare: Collaborating on the Path to Innovation

Publication: Innovation Delaware - Delaware Business Times Special Edition

Delaware leads in gene-editing CRISPR tech

Publication: Delaware Business Times

Delaware BioScience Association Announces Most Promising New Company Competition Winner

Publication: Delaware BioScience Association

CorriXR Therapeutics wins inaugural Delaware DNA pitch contest 

Publication: Delaware Business Times

CRISPR : Can it Cure Disease or is it Playing God?

Podcast: The Smartest Doctor in the Room

This CRISPR Researcher Says Gene Editing Isn't Playing God

Publication: Futurism

Profiles in Innovation: Dr. Eric Kmiec

Publication: Choose Delaware

ChristianaCare explores using CRISPR in cancer treatment, starts talks with FDA

Publication: The Cancer Letter

ChristianaCare Spins Out First Commercial Gene Editing Biotechnology Start-Up Company, CorriXR Therapeutics

Publication: ChristianaCare News

CRISPR Makes Resistant Lung Cancer Cells Vulnerable to Chemotherapy

Publication: CRISPR Medicine News

Gene Editing: Making the Impossible Possible with Drs. Eric Kmiec & Natalia Rivera-Torres

Podcast: Lungcast with the American Lung Association

CRISPR-Induced Gene Products Control Response to Therapy in Lung Cancer Cells

Publication: Genetic Engineering News

Scientists Put CRISPR on Safer Path to Patient Treatments With New Way to Evaluate Impacts of Gene Edits

Publication: ChristianaCare News

Unlike at Other Labs, Women Scientists Thrive at ChristianaCare’s Gene Editing Institute

Publication: ChristianaCare News